Effects of CPB on drug pharmacokinetics

Jens Fassl, Berend Mets

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

The institution of CPB has profound effects on the plasma concentration, distribution and elimination of drugs. The major factors responsible for this are hemodilution, altered plasma protein binding, altered regional blood flow, hypothermia, isolation of the lungs from the circulation and sequestration of drugs into components of the extracorporeal circuit. These changes, which are influenced by physicochemical and pharmacokinetic characteristics, result in an alteration in free drug and effector-site concentration. Hemodilution and plasma protein binding. The CPB circuit is primed with 1500–2000 ml of crystalloid solution corresponding to a potential 30% increase in circulating blood volume with associated hemodilution occurring when CPB is instituted. The immediate effect of this hemodilution is a decrease in circulating drug concentration. The eventual plasma concentration of a drug is dependent on its plasma protein binding, its original volume of distribution and the extent of equilibration between tissue and plasma at the time of institution of CPB. An important consideration is the distinction between the total plasma concentration and the “free” or unbound fraction. The free concentration of the drug is that which moves to the effector site and can be eliminated. The impact of hemodilution on the unbound fraction of drugs tends to be greater for drugs that have high plasma protein binding (PPB). This may result in greater transfer of drug from the blood-prime mixture to the tissues, and thus a lower eventual circulating drug concentration. The volume of distribution (VD) is another factor determining the circulating concentration of drugs during CPB. Drugs with a large inherent VD tend to be less affected by hemodilution, as there is a large tissue reservoir from which the drug can diffuse back into the circulation to plasma.

Original languageEnglish (US)
Title of host publicationCore Topics in Cardiac Anesthesia, Second Edition
PublisherCambridge University Press
Pages71-74
Number of pages4
ISBN (Electronic)9780511979095
ISBN (Print)9780521196857
DOIs
StatePublished - Jan 1 2012

Fingerprint

Pharmacokinetics
Hemodilution
Pharmaceutical Preparations
Protein Binding
Blood Proteins
Regional Blood Flow
Blood Volume
Hypothermia
Lung

All Science Journal Classification (ASJC) codes

  • Medicine(all)

Cite this

Fassl, J., & Mets, B. (2012). Effects of CPB on drug pharmacokinetics. In Core Topics in Cardiac Anesthesia, Second Edition (pp. 71-74). Cambridge University Press. https://doi.org/10.1017/CBO9780511979095.017
Fassl, Jens ; Mets, Berend. / Effects of CPB on drug pharmacokinetics. Core Topics in Cardiac Anesthesia, Second Edition. Cambridge University Press, 2012. pp. 71-74
@inbook{83125227dea84887b46b6a51de632f42,
title = "Effects of CPB on drug pharmacokinetics",
abstract = "The institution of CPB has profound effects on the plasma concentration, distribution and elimination of drugs. The major factors responsible for this are hemodilution, altered plasma protein binding, altered regional blood flow, hypothermia, isolation of the lungs from the circulation and sequestration of drugs into components of the extracorporeal circuit. These changes, which are influenced by physicochemical and pharmacokinetic characteristics, result in an alteration in free drug and effector-site concentration. Hemodilution and plasma protein binding. The CPB circuit is primed with 1500–2000 ml of crystalloid solution corresponding to a potential 30{\%} increase in circulating blood volume with associated hemodilution occurring when CPB is instituted. The immediate effect of this hemodilution is a decrease in circulating drug concentration. The eventual plasma concentration of a drug is dependent on its plasma protein binding, its original volume of distribution and the extent of equilibration between tissue and plasma at the time of institution of CPB. An important consideration is the distinction between the total plasma concentration and the “free” or unbound fraction. The free concentration of the drug is that which moves to the effector site and can be eliminated. The impact of hemodilution on the unbound fraction of drugs tends to be greater for drugs that have high plasma protein binding (PPB). This may result in greater transfer of drug from the blood-prime mixture to the tissues, and thus a lower eventual circulating drug concentration. The volume of distribution (VD) is another factor determining the circulating concentration of drugs during CPB. Drugs with a large inherent VD tend to be less affected by hemodilution, as there is a large tissue reservoir from which the drug can diffuse back into the circulation to plasma.",
author = "Jens Fassl and Berend Mets",
year = "2012",
month = "1",
day = "1",
doi = "10.1017/CBO9780511979095.017",
language = "English (US)",
isbn = "9780521196857",
pages = "71--74",
booktitle = "Core Topics in Cardiac Anesthesia, Second Edition",
publisher = "Cambridge University Press",
address = "United Kingdom",

}

Fassl, J & Mets, B 2012, Effects of CPB on drug pharmacokinetics. in Core Topics in Cardiac Anesthesia, Second Edition. Cambridge University Press, pp. 71-74. https://doi.org/10.1017/CBO9780511979095.017

Effects of CPB on drug pharmacokinetics. / Fassl, Jens; Mets, Berend.

Core Topics in Cardiac Anesthesia, Second Edition. Cambridge University Press, 2012. p. 71-74.

Research output: Chapter in Book/Report/Conference proceedingChapter

TY - CHAP

T1 - Effects of CPB on drug pharmacokinetics

AU - Fassl, Jens

AU - Mets, Berend

PY - 2012/1/1

Y1 - 2012/1/1

N2 - The institution of CPB has profound effects on the plasma concentration, distribution and elimination of drugs. The major factors responsible for this are hemodilution, altered plasma protein binding, altered regional blood flow, hypothermia, isolation of the lungs from the circulation and sequestration of drugs into components of the extracorporeal circuit. These changes, which are influenced by physicochemical and pharmacokinetic characteristics, result in an alteration in free drug and effector-site concentration. Hemodilution and plasma protein binding. The CPB circuit is primed with 1500–2000 ml of crystalloid solution corresponding to a potential 30% increase in circulating blood volume with associated hemodilution occurring when CPB is instituted. The immediate effect of this hemodilution is a decrease in circulating drug concentration. The eventual plasma concentration of a drug is dependent on its plasma protein binding, its original volume of distribution and the extent of equilibration between tissue and plasma at the time of institution of CPB. An important consideration is the distinction between the total plasma concentration and the “free” or unbound fraction. The free concentration of the drug is that which moves to the effector site and can be eliminated. The impact of hemodilution on the unbound fraction of drugs tends to be greater for drugs that have high plasma protein binding (PPB). This may result in greater transfer of drug from the blood-prime mixture to the tissues, and thus a lower eventual circulating drug concentration. The volume of distribution (VD) is another factor determining the circulating concentration of drugs during CPB. Drugs with a large inherent VD tend to be less affected by hemodilution, as there is a large tissue reservoir from which the drug can diffuse back into the circulation to plasma.

AB - The institution of CPB has profound effects on the plasma concentration, distribution and elimination of drugs. The major factors responsible for this are hemodilution, altered plasma protein binding, altered regional blood flow, hypothermia, isolation of the lungs from the circulation and sequestration of drugs into components of the extracorporeal circuit. These changes, which are influenced by physicochemical and pharmacokinetic characteristics, result in an alteration in free drug and effector-site concentration. Hemodilution and plasma protein binding. The CPB circuit is primed with 1500–2000 ml of crystalloid solution corresponding to a potential 30% increase in circulating blood volume with associated hemodilution occurring when CPB is instituted. The immediate effect of this hemodilution is a decrease in circulating drug concentration. The eventual plasma concentration of a drug is dependent on its plasma protein binding, its original volume of distribution and the extent of equilibration between tissue and plasma at the time of institution of CPB. An important consideration is the distinction between the total plasma concentration and the “free” or unbound fraction. The free concentration of the drug is that which moves to the effector site and can be eliminated. The impact of hemodilution on the unbound fraction of drugs tends to be greater for drugs that have high plasma protein binding (PPB). This may result in greater transfer of drug from the blood-prime mixture to the tissues, and thus a lower eventual circulating drug concentration. The volume of distribution (VD) is another factor determining the circulating concentration of drugs during CPB. Drugs with a large inherent VD tend to be less affected by hemodilution, as there is a large tissue reservoir from which the drug can diffuse back into the circulation to plasma.

UR - http://www.scopus.com/inward/record.url?scp=85011343801&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85011343801&partnerID=8YFLogxK

U2 - 10.1017/CBO9780511979095.017

DO - 10.1017/CBO9780511979095.017

M3 - Chapter

AN - SCOPUS:85011343801

SN - 9780521196857

SP - 71

EP - 74

BT - Core Topics in Cardiac Anesthesia, Second Edition

PB - Cambridge University Press

ER -

Fassl J, Mets B. Effects of CPB on drug pharmacokinetics. In Core Topics in Cardiac Anesthesia, Second Edition. Cambridge University Press. 2012. p. 71-74 https://doi.org/10.1017/CBO9780511979095.017